Press Releases

 
Press Releases
  Date Title View
Apr 1, 2015
2014 and Recent Operational Highlights Record revenue in 2014 of EUR 26.8 million (USD 35.4 million); 11% growth over the previous year; Full-year HIFU revenue increased 70% over 2013; Strong Cash position of EUR 12.1 million (USD 14.7 million) as of December 31, 2014; Filing Direct De Novo petition for A...
Mar 31, 2015
LYON, France, March 31, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first sale of Focal One HIFU device to Jewish General Hospital, Montreal, Canada. This sale occurs only two months after the Company gained Health Canada's approval to market its Focal One HIFU device for foca...
Mar 26, 2015
LYON, France, March 26, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the Company's participation in a major collaborative liver cancer project aimed at developing innovative new therapies for this prevalent indication. "HECAM" (HEpatocellular CArcinoma Multi-technological) ...
Mar 17, 2015
LYON, France, March 17, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the fourth quarter and year ended December 31, 2014 on Thursday, April 2, 2015, during pre-market hours. Company management will host a conference call on Thu...
Mar 9, 2015
LYON, France, March 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that, based on a recent meeting with the U.S. Food and Drug Administration ("FDA"), the Company plans to seek clearance of Ablatherm HIFU by way of a Direct De Novo 510(k) application as opposed to the Pre-Market A...
Feb 26, 2015
LYON, France, Feb. 26, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced a multi-national strategic OEM partnership with Quanta System, a leading manufacturer of medical lasers for surgical and other applications. Under the agreement, Quanta will manufacture customized urological stone ...
Jan 9, 2015
LYON, France, Jan. 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its Focal One HIFU device has been approved by Health Canada. With this approval, the Company is able to market the Focal One device for the treatment of prostate cancer in Canada. Marc Oczachowski, EDA...
Nov 20, 2014
Highlights Revenues increased 27% year-over-year to EUR 20.3 million (USD 27.4 million) for the first nine months of 2014 HIFU revenue increased 114% year-over-year during first nine months of 2014 Positive operating income, excluding FDA-related costs, for three and nine months ended September 30, 2014 S...
Nov 6, 2014
LYON, France, Nov. 6, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today received a letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on its current PMA application for Ablatherm Integrated Imaging Device. The FDA letter stated that while E...
Nov 4, 2014
LYON, France, Nov. 4, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Thursday, November 20, 2014, during pre-market hours. Company management will host a conference call on Thursday, ...
1
... NextLast
= add release to Briefcase